Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Nature Publishing" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Nature Publishing for you to read. Along with our medical data and news we also list Nature Publishing Clinical Trials, which are updated daily. BioPortfolio also has a large database of Nature Publishing Companies for you to search.
Direct-acting antiviral agents (DAAs) are highly effective treatments for HCV, but are not always accessible to people who inject drugs (PWID). Here, Grebely and colleagues outline the epidemiology of HCV in PWID, discuss current data on DAA outcomes in this population and highlight steps required to broaden access to HCV therapy with the eventual goal of HCV elimination.
Brain-region-specific RNA-seq from humans with major depressive disorder reveals unique transcriptomic profiles in males and females, with little overlap.
On the basis of new mechanistic studies of a mutant form of the apolipoprotein apoC-III that protects against coronary heart disease, Khetarpal et al. have developed therapeutic apoC-III-targeting monoclonal antibodies that lower circulating apoC-III protein and triglyceride levels in mice.
Genetic or pharmacological depletion of senescent cells or inhibition of their function reduces bone loss in aged mice.
Few clinical trials incorporate studies of evolutionary cancer biology, despite the frequent emergence of acquired resistance to anticancer therapies. This problem motivated the first CRUK Marshall Symposium on Cancer Evolution in May 2017, which provided a forum for evolutionary and ecological theorists, cancer biologists, and clinicians to consider how evolutionary biology might inform improveme...